Spotlight Therapeutics

Spotlight therapeutics. In vivo gene editing. Illuminating life-changing therapeutics. Back to Top. Contact us. Spotlight Therapeutics 3980 Trust Way Hayward, ...

Spotlight Therapeutics - IPIRA-Berkeley

Developer of next-generation gene editing therapeutics in a preclinical pipeline. The company creates programmable nucleases that selectively target and edit ...

Spotlight Therapeutics - Crunchbase Company Profile & Funding

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

Spotlight Therapeutics' cell-specific in vivo gene editing platform ...

Spotlight's TAGE enable cell-selective gene editing of undruggable targets in the TME without the need for viral or nanoparticle delivery.

Spotlight Therapeutics - Valuation, Funding & Investors - PitchBook

Information on valuation, funding, cap tables, investors, and executives for Spotlight Therapeutics. Use the PitchBook Platform to explore the full profile.

Spotlight Therapeutics Raises $36.5 Million Series B to Advance a ...

A biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today announced a $36.5M Series B financing to ...

Spotlight Therapeutics: making CRISPR deliver in vivo - Nature

Moving beyond viral vectors and lipid nanoparticles, Spotlight is conjugating Cas proteins to agents that will home endonucleases and their ...

Company: Spotlight Therapeutics - CRISPR Medicine News

Spotlight Therapeutics ... Spotlight Therapeutics is an early stage pre-clinical gene-editing company. Spotlight is focused on developing first-in-class in vivo ...

Spotlight Therapeutics Company Profile: Overview and Full News ...

Spotlight Therapeutics is a biotechnology company based in California, specifically located in Hayward. The company is focused on developing innovative ...

Spotlight Therapeutics Inc. - BioCentury Company Profiles - BCIQ

Spotlight Therapeutics Inc. - BioCentury Company Profiles for the biopharma industry.

spotlight therapeutics - Recipient Information | HHS TAGGS

Issue Date FY: 2024. Funding FY: 2023. Legal Entity Name: SPOTLIGHT THERAPEUTICS. Legal Entity Address: 3953 POINT EDEN WAY. Legal Entity City: HAYWARD.

Startup unifies lab management to pave the way for Big Data analytics

Spotlight Therapeutics is pioneering cell-targeted in vivo CRISPR gene editing by creating a new class of programmable ribonucleoproteins called Targeted ...

Spotlight Therapeutics - Parker Institute for Cancer Immunotherapy

Develop breakthrough immune therapies to turn all cancers into curable diseases faster ... Change lives. Donate. Spotlight Therapeutics. Get Email Updates. Email

Spotlight Therapeutics Inc. - [LSUS] Life-Sciences-USA.com

Established in mid-2018, Spotlight Therapeutics is a privately held biotechnology company advancing a pipeline of first-in-class cell-targeted CRISPR gene ...

Spotlight Therapeutics Stock Price, Funding, Valuation ... - CB Insights

See Spotlight Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Spotlight Therapeutics's post-money ...

Spotlight Therapeutics, Inc. - Patsnap Synapse

Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and ...

Mary Haak-Frendscho - Spotlight Therapeutics | LinkedIn

Entrepreneurial biotechnology executive experienced in both private and public companies… · Experience: Spotlight Therapeutics · Education: Columbia ...

Spotlight Therapeutics, Inc. Asset Profile | Preqin

Founded in 2017 and based in California, US, Spotlight Therapeutics, Inc. operates as a biotechnology company that develops a new class of biologics for ...

Spotlight Therapeutics Inc - BIO International Convention 2024

Participating Companies. Spotlight Therapeutics Inc. Biotech or pharma, therapeutic R&D.

B-cell therapy biotech Walking Fish closes down

Kim joined from Quan after stints at Genentech and Roche, while Arvindan was the former CTO at Spotlight Therapeutics. Related. 4 years after ...

Spotlight Therapeutics

Investor Spotlight: Ridgeline Therapeutics – A Versant Ventures Discovery Engine